"","V1","V2","V3","V4","V5","V6","V7","V8","V9","V10","V11","V12","V13","V14","V15","V16","V17","V18","V19","V20","V21","V22","V23","V24","V25","V26","V27","V28","V29","V30","V31","V32","V33","V34","V35","V36","V37","V38","V39","V40","V41","V42","V43","V44","V45","V46","V47","V48","V49","V50","V51","V52","V53","V54","V55","V56","V57","V58","V59","V60","V61","V62","V63","V64","V65","V66","V67","V68","V69","V70","V71","V72","V73","V74","V75","V76","V77","V78","V79","V80","V81","V82","V83","V84","V85","V86","V87","V88","V89","V90","V91","V92","V93","V94","V95","V96","V97","V98","V99","V100","V101","V102","V103","V104","V105","V106","V107","V108","V109","V110","V111","V112","V113","V114","V115","V116","V117","V118","V119","V120","V121","V122","V123","V124","V125","V126","V127","V128","V129","V130","V131","V132","V133","V134","V135","V136","V137","V138","V139","V140","V141","V142","V143","V144","V145","V146","V147","V148","V149","V150","V151","V152","V153","V154","V155","V156","V157","V158","V159","V160","V161","V162","V163","V164","V165","V166","V167","V168","V169","V170","V171","V172","V173","V174","V175","V176","V177","V178","V179","V180","V181","V182"
"1","abs277.txt","objective","","this","study","explored","neoplasm","risk","with","liraglutide","versus","placebo","inthe","leader","(liraglutide","effect","and","action","in","diabetes","evaluation","ofcardiovascular","outcome","results)","cohort","research","design","methods","(nct01179048)","was","an","international","phase","3b","randomized","double-blind","controlled","trial","participants","aged","≥50","years","type2","high","cardiovascular","were","assigned","1","to","receive","liraglutide(≤1","8","mg","daily","n","=","4","668)","or","(n","672)","addition","standard","careand","monitored","for","3","5-5","(median","follow-up","years)","the","occurrence","ofneoplasms","a","prespecified","exploratory","secondary","end","point","post","hoc","analysesof","time","first","confirmed","neoplasms","conducted","using","coxregression","model","results","10","1%","of","patients","9","0%with","(hazard","ratio","[hr]","12","[95%","ci","0","99","28])","hr","(95%","ci)","forliraglutide","06","(0","90","25)","malignant","16(0","93","44)","benign","sensitivity","analyses","excluding","neoplasmsoccurring","<1","year","<2","after","randomization","by","sex","providedsimilar","our","main","95%","included","one","allmalignant","evaluated","(including","pancreatic","thyroid","neoplasms)","exceptfor","prostate","which","occurred","fewer","liraglutide-treated","conclusions","not","primarily","designed","assess","firmconclusions","cannot","be","made","regarding","numeric","imbalances","observed","individualneoplasm","types","(e","g","cancer)","that","infrequently","datado","however","exclude","major","increase","total","neoplasmswith","additional","studies","are","needed","assesslonger-term","exposure"
